Business Wire

ADVA announces record Q4 2020 results and reports full year 2020 figures

Share

ADVA (ISIN: DE0005103006), a leading provider of open networking solutions for the delivery of cloud and mobile services, reported financial results for Q4 2020 and full year 2020 ended on December 31, 2020. The results have been prepared in accordance with International Financial Reporting Standards (IFRS).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005994/en/

Brian Protiva, CEO, ADVA (Photo: Business Wire)

Brian Protiva, CEO, ADVA (Photo: Business Wire)

Q4 2020 financial summary1

(in thousands of EUR)

Q4

Q4

Change

Q3

Change

2020

2019

2020

Revenues

140,572

151,135

-7.0%

146,676

-4.2%

Pro forma gross profit

54,641

54,633

0.0%

51,930

5.2%

in % of revenues

38.9%

36.1%

2.8pp

35.4%

3.5pp

Pro forma operating income

14,343

10,333

38.8%

11,053

29.8%

in % of revenues

10.2%

6.8%

3.4pp

7.5%

2.7pp

Operating income (loss)

13,085

5,438

140.6%

9,768

34.0%

Net income

13,249

2,522

425.3%

6,671

98.6%

(in thousands of EUR)

Dec. 31

Dec. 31

Change

Sep. 30

Change

2020

2019

2020

Cash and cash equivalents

64,881

54,263

19.6%

68,293

-5.0%

Net debt

25,545

61,146

-58.2%

35,009

-27.0%

Net working capital

129,853

128,150

1.3%

124,043

4.7%

1 Potential difference due to rounding

Q4 2020 IFRS financial results
Revenues in Q4 2020 reached EUR 140.6 million, down by 4.2% from EUR 146.7 million in Q3 2020 and down by 7.0% compared to EUR 151.1 million in the same year-ago period. The decrease in revenues is primarily due to the devaluation of the US dollar compared to the euro. In addition, due to lockdown tightening again, some orders had to be postponed to the following quarter.

Pro forma gross profit in Q4 2020 increased by 5.2%, reaching EUR 54.6 million (38.9% of revenues) compared to EUR 51.9 million (35.4% of revenues) in Q3 2020. Compared to EUR 54.6 million reported in the year-ago quarter, pro forma gross profit remained stable in absolute terms. However, in relation to revenues, an increase of 2.8 percentage points from 36.1% to 38.9% was achieved. This increase can mainly be attributed to the stronger euro compared to the US dollar. Compared to the year-ago quarter, Q4 2020 benefited from lower US tariffs due to the relocation of production facilities out of China. In addition, the above-average profitable technology area of network synchronization recorded a very successful final quarter.

Pro forma operating income for Q4 2020 was EUR 14.3 million (10.2% of revenues) and increased considerably by 29.8% compared to EUR 11.1 million (7.5% of revenues) in Q3 2020. Compared to the year-ago quarter, pro forma operating income improved substantially by 38.8% from EUR 10.3 million (6.8% of revenues). In addition to the higher gross profit, this substantial margin improvement is mainly due to the cost improvement measures introduced in 2019 and reduced discretionary spending.

Consequently, operating income for Q4 2020 of EUR 13.1 million increased by 34.0% from EUR 9.8 million reported for Q3 2020 and significantly increased by 140.6% from EUR 5.4 million in the same year-ago quarter. While Q4 2019 was negatively impacted by one-off expenses of EUR 3.2 million resulting from the introduced cost improvement measures, Q4 2020 was positively impacted by the renewed cost basis.

Net income reached EUR 13.2 million in Q4 2020, substantially up by 98.6% from EUR 6.7 million in Q3 2020 and significantly up by 425.3% from EUR 2.5 million in Q4 2019.

The company’s cash and cash equivalents totaled EUR 64.9 million, representing a slight decrease of EUR 3.4 million compared to EUR 68.3 million at the end of Q3 2020. Year-over-year cash and cash equivalents substantially increased by EUR 10.6 million from EUR 54.3 million at the end of Q4 2019. The higher cash balance is mainly the result of the improved profitability.

Consequently, net debt in Q4 2020 decreased by EUR 9.5 million to EUR 25.5 million from EUR 35.0 million at the end of Q3 2020 and improved significantly by EUR 35.6 million compared to Q4 2019 (EUR 61.1 million).

Net working capital at quarter-end was EUR 129.9 million and increased by EUR 5.9 million compared to EUR 124.0 million at the end of Q3 2020. This was particularly due to measures to maintain the supply chain and the associated reduction in trade payables.

Full year 2020 financial summary1

(in thousands of EUR)

2020

2019

Change

Revenues

564,958

556,821

1.5%

Pro forma gross profit

199,050

195,364

1.9%

in % of revenues

35.2%

35.1%

0.1pp

Pro forma operating income

33,832

24,811

36.4%

in % of revenues

6.0%

4.5%

1.5pp

Operating income (loss)

27,473

12,003

128.9%

Net income

20,314

7,045

188.3%

(in thousands of EUR)

Dec. 31 2020

Dec. 31 2019

Change

Cash and cash equivalents

64.881

54,263

19.6%

Net debt

25,545

61,146

-58.2%

Net working capital

129,853

128,510

1.3%

1 Potential differences due to rounding

Full year 2020 IFRS financial results
For the full year 2020, revenues increased by 1.5% from EUR 556.8 million in 2019 to EUR 565.0 million. Revenues were at the lower end of the guidance corridor of between EUR 565 million and 580 million. Despite the current pandemic, demand in 2020 was robust. Home office, the increased use of e-learning, video conferencing and streaming services have increased network utilization significantly, while investments in network access solutions for enterprises have decreased. On the other hand, the US dollar, which continued to weaken against the euro, had a negative impact on US-denominated revenues, especially in the second half of the year.

Pro forma gross profit increased by 1.9% from EUR 195.4 million in 2019 to EUR 199.1 million in 2020. While in the first half of the year, gross profit was negatively impacted, particularly by the effects of the Covid-19 pandemic, the second half of the year benefited from revenues with higher margins and the ongoing US dollar devaluation.

Pro forma operating income for 2020 significantly increased by 36.4% from 24.8 million or 4.5% of revenues in 2019 to EUR 33.8 million or 6.0% of revenues. Pro forma operating income was at the top end of the guidance corridor of between EUR 5.0% and 6.0%. In addition to the higher gross profit, this substantial margin improvement is mainly due to the cost improvement measures introduced in 2019 and reduced discretionary spending.

Operating income for 2020 reached EUR 27.5 million compared to EUR 12.0 million in 2019 and increased significantly by 128.9%. While the previous year was negatively impacted by EUR 5.7 million one-off expenses in connection with the cost reduction measures, the improved cost base in 2020 contributed positively to profitability.

Consequently, net income increased significantly from EUR 7.0 million in 2019 by 188.3% to EUR 20.3 million in 2020.

Basic and diluted earnings per share in 2020 amounted to EUR 0.40, both compared to basic and diluted earnings per share of EUR 0.14 in 2019.

Management commentary
“Today’s communication infrastructure is critical to solving some of the biggest challenges facing our global society. And we are a key part of this process. We are the only remaining optical networking and synchronization specialist in Europe. Growing safety concerns, specifically around the major Chinese equipment suppliers, create new opportunities and unique selling points for us that further strengthen our market position,” said Brian Protiva, CEO, ADVA. “Technologically, our solutions are perfectly aligned with the network transformation that’s taking place, including a focus on cloud, mobility, 5G, network automation and security. With our investments, we’ve created a foundation for transforming our business model towards higher margins. This transformation includes growing revenue contributions from software and services, expansion into new industries and further verticalization of our business.”

“2020 was a challenging but very successful year for us. At the beginning of the pandemic, the uncertainties were high. However, we responded quickly to ensure that we could navigate through the crisis as best as possible. As a result, we’re reporting today one of the most successful financial years in the company’s history. In the final quarter, our pro forma operating income was even at 10.2% – a number that we have never achieved before,” commented Uli Dopfer, CFO, ADVA. “In addition, we were able to reduce our net debt substantially by EUR 36 million to around EUR 25 million – without the application of IFRS 16 this would correspond to net cash of around EUR 2 million. Therefore, we decided to terminate the KfW back-up line early in January. We are very confident about the coming year and started the new quarter with a well-filled order book and a favorable customer and product mix.”

Financial outlook 2021
For the fiscal year 2021, ADVA expects revenues to be in the range of EUR 580 million and EUR 610 million and a pro forma operating income of between 6.0% and 9.0% of revenues. For Q1 2021, the company expects revenues to be in the range of EUR 143 million and EUR 148 million and a proforma operating income of between 7.0% and 9.0% of revenues.

The company will publish its financial results for Q1 2021 on April 22, 2021.

Conference call details
ADVA will hold a conference call for analysts and investors today, February 25, 2021, to discuss the Q4 2020 and full year 2020 results. The company’s CEO, Brian Protiva, and CFO, Uli Dopfer, will host the call at 3:00 p.m. CET (9:00 a.m. EST). A question and answer session will follow management presentations.

A corresponding presentation is available on ADVA’s website: https://www.adva.com/en/about-us/investors/financial-results/conference-calls

The complete annual report 2020 (January – December) is available as a PDF here: https://www.adva.com/en/about-us/investors/financial-results/financial-statements

A replay of the call will be available here: https://www.adva.com/en/about-us/investors/financial-results/conference-calls

Forward-looking statements
The economic projections and forward-looking statements contained in this document relate to future facts. Such projections and forward-looking statements are subject to risks that cannot be foreseen and that are beyond the control of ADVA. ADVA is therefore not in a position to make any representation as to the accuracy of economic projections and forward-looking statements or their impact on the financial situation of ADVA or the market in the shares of ADVA.

Use of pro forma financial information
ADVA provides consolidated pro forma financial results in this press release solely as supplemental financial information to help investors and the financial community make meaningful comparisons of ADVA’s operating results from one financial period to another. ADVA believes that these pro forma consolidated financial results are helpful because they exclude non-cash charges related to the stock option programs and amortization and impairment of goodwill and acquisition-related intangible assets, which are not reflective of the company’s operating results for the period presented. Additionally, expenses related to restructuring measures are not included. This pro forma information is not prepared in accordance with IFRS and should not be considered a substitute for the historical information presented in accordance with IFRS.

About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

Contact information

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

For press:
Gareth Spence
+44 1904 699 358
public-relations@adva.com

For investors:
Steven Williams
+49 89 890 66 59 18
investor-relations@adva.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

RoboSense Teams Up With Webasto On Smart Roof Module With Integrated MEMS LiDAR23.4.2021 20:00:00 CEST | Press release

During the Shanghai Auto Show, RoboSense (https://robosense.ai/), a smart and automotive LiDAR system provider, and Webasto (https://www.webasto-group.com/), the global Top 100 automotive supplier and market leader for roof systems, announced cooperation on the Smart Roof Sensor Module that integrated with RoboSense automotive-grade MEMS LiDAR RS-LiDAR-M1 for Level 3 to Level 5 autonomous driving vehicles, largely simplifying the structure and mounting process of conventional sensor sets of self-driving vehicles and ensures advanced safety perception. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210423005484/en/ The M1 is seamlessly embedded into Webasto Roof Sensor Module (Photo: Business Wire) Through this strategic cooperation, Webasto is committed to seamlessly embedding the RoboSense M1, camera and other sensor systems to the panoramic roof of vehicles to provide safer and more reliable environment perception informat

LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 202123.4.2021 16:05:00 CEST | Press release

LEO Pharma A/S, a global leader in medical dermatology, today announced results on the long-term safety and efficacy profile of tralokinumab in adult patients with moderate-to-severe atopic dermatitis. Results were shared as an oral presentation during the American Academy of Dermatology Virtual Meeting Experience (AAD VMX) 2021. Tralokinumab is a high affinity, human monoclonal antibody that specifically binds to and inhibits the IL-13 cytokine, a key driver of atopic dermatitis signs and symptoms.2,3 It is an investigational therapy in clinical development, and its safety and efficacy are currently being evaluated by regulatory authorities. The interim analysis at 56 weeks in the ECZTEND trial (NCT03587805) showed tralokinumab 300 mg every other week plus optional topical corticosteroids (TCS) demonstrated long-term improvements in itch, sleep, and in atopic dermatitis signs and symptoms.1 Patients who had enrolled in pivotal Phase 3 trials ECZTRA 1 and 2 who continued into ECZTEND w

Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD ® Use During the COVID-19 Pandemic23.4.2021 15:11:00 CEST | Press release

Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced a new analysis from the MAGNIFY-MS sub-study showing a specific immune repopulation pattern in patients with relapsing multiple sclerosis (RMS) treated with MAVENCLAD® (cladribine tablets), which may contribute to their ability to fight infections and develop protective antibodies from vaccines. The data were presented at the 2021 American Academy of Neurology (AAN) Annual Meeting that was held virtually 17-22 April 2021. In the MAGNIFY-MS study, reduction of memory B cells occurred as early as one month after MAVENCLAD initiation with lowest levels sustained for up to 12 months, while naïve B cells, which are typically required for the generation of antibody responses following vaccination, began recovering immediately. Previously shared data from MAGNIFY-MS indicated that patients receiving MAVENCLAD are able to mount responses to influenza and varicella zoster vaccines, irrespec

Xsolla Offers Exit Strategies to Game Studios for Exit Advising and Planning23.4.2021 15:00:00 CEST | Press release

Xsolla, the video game commerce company powered by its Transaction Engine and Business Engine to help developers and publishers market, sell, connect and optimize their games globally, has announced Xsolla Exit Strategies. The new service will connect development studios with financial and transaction advisors, guiding them through the process of selling their game property or studio, from due diligence preparation to exiting. The unveil of Xsolla Exit Strategies comes full circle from Xsolla Funding Club, launched March 2019, which provides matchmaking between vetted game projects and qualified investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210423005013/en/ Let Xsolla Exit Strategies match you with a financial and transaction advisor to help meet your exit goals. (Graphic: Business Wire) The gaming industry continues to flourish as demand is high for strategic partnerships and acquisitions for both game companies

Wipro Achieves Google Cloud Partner Specialization in Application Development23.4.2021 14:33:00 CEST | Press release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has achieved the Google Cloud Partner Specialization in application development. This marks the fourth Partner Specialization badge that Wipro has received from Google Cloud, following recognition for outstanding cloud security, migration, and work transformation. This specialization demonstrates Wipro’s capabilities across multiple areas as a Google Cloud SI partner. As a trusted Google Cloud partner, Wipro can help customers leverage the best of Google Cloud platform as they develop and manage cloud-native business applications, enabling faster time to market, increasing scalability of applications and integrating them with external and internal systems in the IT landscape. This specialization will allow Wipro’s team of certified professionals to accelerate the customer modernization journey, increase agility and adapta

LEO Pharma Receives Positive CHMP Opinion of Adtralza ® (tralokinumab) for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis23.4.2021 13:59:00 CEST | Press release

LEO Pharma A/S, a global leader in medical dermatology, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization of Adtralza® (tralokinumab) for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy. The CHMP positive opinion is one of the final steps before the European Commission makes its decision on the Marketing Authorization Application for use of Adtralza, an investigational therapy in clinical development, throughout the European Union. This final decision is expected in the coming months and if authorized, Adtralza will be the first fully human, monoclonal antibody available to specifically target the IL-13 cytokine, a key driver of atopic dermatitis signs and symptoms. Adtralza specifically targets IL-13 with high affinity and is developed to improve the symptoms of atopic derma

Schlumberger Announces First-Quarter 2021 Results23.4.2021 12:50:00 CEST | Press release

Schlumberger Limited (NYSE: SLB) today reported results for the first-quarter 2021. First-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChange Mar. 31, 2021 Dec. 31, 2020 Mar. 31, 2020 SequentialYear-on-yearRevenue* $5,223 $5,532 $7,455 -6% -30% Income (loss) before taxes - GAAP basis $386 $471 $(8,089) -18% n/m Net income (loss) - GAAP basis $299 $374 $(7,376) -20% n/m Diluted EPS (loss per share) - GAAP basis $0.21 $0.27 $(5.32) -22% n/m Adjusted EBITDA** $1,049 $1,112 $1,347 -6% -22% Adjusted EBITDA margin** 20.1% 20.1% 18.1% 0 bps 203 bps Pretax segment operating income** $664 $654 $776 1% -14% Pretax segment operating margin** 12.7% 11.8% 10.4% 88 bps 230 bps Net income, excluding charges & credits** $299 $309 $351 -3% -15% Diluted EPS, excluding charges & credits** $0.21 $0.22 $0.25 -5% -16% Revenue by Geography International $4,211 $4,343 $5,225 -3% -19% North America* 972 1,167 2,180 -17% -55% Other 40 22 50 n/m n/m $5,223 $5,532 $7,455 -6% -30%